Compare Stocks: NNOX, INGN, STIM, and FOCL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOCL FocalTherics	$4.20 -2.3%	$4.49	$1.75 ▼ $6.40	$161.37M	-0.06	73,873 shs	50,523 shs
INGN Inogen	$6.34 -1.2%	$5.60	$5.05 ▼ $9.13	$170.38M	1.5	413,635 shs	293,054 shs
NNOX Nano-X Imaging	$0.51 +0.9%	$0.79	$0.50 ▼ $4.71	$40.08M	1.28	872,183 shs	729,614 shs
STIM Neuronetics	$1.99 -6.6%	$2.73	$0.80 ▼ $3.44	$162.30M	1.19	892,550 shs	547,938 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOCL FocalTherics	-2.33%	-1.64%	+2.44%	-23.08%	+419,999,900.00%
INGN Inogen	-1.25%	+9.88%	+19.40%	-1.09%	-21.14%
NNOX Nano-X Imaging	+0.90%	-16.38%	-28.90%	-53.22%	-87.33%
STIM Neuronetics	-6.57%	-9.95%	-34.32%	+8.15%	-27.90%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FOCL FocalTherics	$4.20 -2.3%	$4.49	$1.75 ▼ $6.40	$161.37M	-0.06	73,873 shs	50,523 shs
INGN Inogen	$6.34 -1.2%	$5.60	$5.05 ▼ $9.13	$170.38M	1.5	413,635 shs	293,054 shs
NNOX Nano-X Imaging	$0.51 +0.9%	$0.79	$0.50 ▼ $4.71	$40.08M	1.28	872,183 shs	729,614 shs
STIM Neuronetics	$1.99 -6.6%	$2.73	$0.80 ▼ $3.44	$162.30M	1.19	892,550 shs	547,938 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FOCL FocalTherics	-2.33%	-1.64%	+2.44%	-23.08%	+419,999,900.00%
INGN Inogen	-1.25%	+9.88%	+19.40%	-1.09%	-21.14%
NNOX Nano-X Imaging	+0.90%	-16.38%	-28.90%	-53.22%	-87.33%
STIM Neuronetics	-6.57%	-9.95%	-34.32%	+8.15%	-27.90%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FOCL FocalTherics	2.40	Hold	$7.75	84.52% Upside
INGN Inogen	2.50	Moderate Buy	N/A	N/A
NNOX Nano-X Imaging	2.50	Moderate Buy	$4.33	742.08% Upside
STIM Neuronetics	2.60	Moderate Buy	$4.67	134.51% Upside

Current Analyst Ratings Breakdown

Latest NNOX, INGN, STIM, and FOCL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/2/2026	NNOX Nano-X Imaging	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
9/17/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$6.00
9/14/2026	STIM Neuronetics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
9/11/2026	STIM Neuronetics	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy
9/11/2026	STIM Neuronetics	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$5.00
9/9/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$6.00
8/25/2026	FOCL FocalTherics	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$10.00
8/17/2026	FOCL FocalTherics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
8/17/2026	NNOX Nano-X Imaging	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Overweight	$5.00
8/14/2026	FOCL FocalTherics	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Neutral	$4.00
8/11/2026	STIM Neuronetics	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$5.00 ➝ $6.00

(Data available from 10/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FOCL FocalTherics	$70.53M	2.23	N/A	N/A	$0.52 per share	8.08
INGN Inogen	$348.67M	0.48	N/A	N/A	$7.08 per share	0.90
NNOX Nano-X Imaging	$13.02M	3.11	N/A	N/A	$2.01 per share	0.26
STIM Neuronetics	$149.16M	1.02	N/A	N/A	$0.38 per share	5.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FOCL FocalTherics	-$29.25M	-$1.03	N/A	N/A	N/A	-56.26%	-248.00%	-44.69%	N/A
INGN Inogen	-$22.75M	-$0.90	N/A	N/A	N/A	-6.94%	-13.17%	-8.36%	11/4/2026 (Estimated)
NNOX Nano-X Imaging	-$75.02M	-$2.14	N/A	N/A	N/A	-926.05%	-116.93%	-100.67%	11/19/2026 (Estimated)
STIM Neuronetics	-$39M	-$0.44	N/A	N/A	N/A	-19.62%	-125.11%	-22.15%	11/3/2026 (Estimated)

Latest NNOX, INGN, STIM, and FOCL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/4/2026	Q3 2026	INGN Inogen	-$0.11	N/A	N/A	N/A	$92.23 million	N/A
11/3/2026	Q3 2026	STIM Neuronetics	-$0.08	N/A	N/A	N/A	$40.43 million	N/A
9/9/2026	Q2 2026	NNOX Nano-X Imaging	-$0.1620	-$0.79	-$0.6280	-$0.79	$5.38 million	$4.16 million
8/14/2026	Q2 2026	FOCL FocalTherics	-$0.20	-$0.39	-$0.19	-$0.39	N/A	$13.20 million
8/11/2026	Q2 2026	STIM Neuronetics	-$0.1230	-$0.05	+$0.0730	-$0.05	$40.17 million	$41.57 million
8/6/2026	Q2 2026	INGN Inogen	-$0.1533	-$0.14	+$0.0133	-$0.14	$95.23 million	$95.08 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
FOCL FocalTherics	N/A	N/A	N/A	N/A	N/A
INGN Inogen	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FOCL FocalTherics	1.79	1.60	1.38
INGN Inogen	N/A	2.74	2.34
NNOX Nano-X Imaging	N/A	2.84	2.59
STIM Neuronetics	2.84	1.88	1.69

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FOCL FocalTherics	62.74%
INGN Inogen	89.94%
NNOX Nano-X Imaging	21.49%
STIM Neuronetics	53.59%

Insider Ownership

Company	Insider Ownership
FOCL FocalTherics	10.10%
INGN Inogen	2.50%
NNOX Nano-X Imaging	N/A
STIM Neuronetics	8.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FOCL FocalTherics	230	37.53 million	33.74 million	N/A
INGN Inogen	753	26.54 million	25.88 million	Optionable
NNOX Nano-X Imaging	197	78.59 million	N/A	Optionable
STIM Neuronetics	658	76.20 million	69.80 million	Optionable

NNOX, INGN, STIM, and FOCL Headlines

Recent News About These Companies

Harmony Biosciences Names Peter Anastasiou CEO Effective January 1, 2027; Reaffirms 2026 WAKIX Guidance

October 12 at 7:31 AM | quiverquant.comQ

Neuronetics stock gained 1.85 percent after Q2 revenue beat

October 6, 2026 | ad-hoc-news.deA

Neuronetics, Inc. (NASDAQ:STIM) Stock Has Average Target Price of $4.67 According to Brokerages

October 6, 2026 | americanbankingnews.com

Neuronetics, Inc. (NASDAQ:STIM) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages

October 6, 2026 | marketbeat.com

Neuronetics stock fell 2.70 percent as Q2 growth emerged

October 4, 2026 | ad-hoc-news.deA

Neuronetics stock holds after August 11 earnings beat

September 19, 2026 | ad-hoc-news.deA

BTIG Research Reiterates Buy Rating for Neuronetics (NASDAQ:STIM)

September 17, 2026 | marketbeat.com

B Riley Securities initiates coverage of Neuronetics at buy

September 12, 2026 | msn.com

B. Riley Initiates Neuronetics at Buy With $5 Price Target

September 11, 2026 | marketscreener.comM

NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System

September 8, 2026 | globenewswire.com

Neuronetics (STIM) Q2 2026 Earnings Call Transcript

August 18, 2026 | finance.yahoo.com

Neuronetics (NASDAQ:STIM) Major Shareholder Acquires 14,000 Shares of Stock

August 18, 2026 | insidertrades.com

Neuronetics, Inc. (STIM) Q2 FY2026 earnings call transcript

August 12, 2026 | finance.yahoo.com

Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ...

August 12, 2026 | finance.yahoo.com

Neuronetics: Q2 Earnings Snapshot

August 11, 2026 | wtop.comW

Neuronetics Reports Second Quarter 2026 Financial and Operating Results

August 11, 2026 | markets.businessinsider.com

Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

Neuronetics narrows Q2 loss as Greenbrook growth drives 9% revenue increase

August 11, 2026 | msn.com

Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates

August 11, 2026 | zacks.com

Neuronetics Reports Second Quarter 2026 Results, Highlights Revenue Growth and Improved Adjusted EBITDA

August 11, 2026 | quiverquant.comQ

Malvern’s Neuronetics reaches deal with shareholder who pushed to break up company

August 5, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NNOX, INGN, STIM, and FOCL Company Descriptions

FocalTherics NASDAQ:FOCL

$4.20 -0.10 (-2.33%)

As of 10/13/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

Inogen NASDAQ:INGN

$6.34 -0.08 (-1.25%)

Closing price 10/13/2026 04:00 PM Eastern

Extended Trading

$6.34 +0.00 (+0.08%)

As of 10/13/2026 07:30 PM Eastern

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Nano-X Imaging NASDAQ:NNOX

$0.51 +0.00 (+0.90%)

Closing price 10/13/2026 04:00 PM Eastern

Extended Trading

$0.52 +0.01 (+1.24%)

As of 10/13/2026 07:59 PM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Neuronetics NASDAQ:STIM

$1.99 -0.14 (-6.57%)

Closing price 10/13/2026 04:00 PM Eastern

Extended Trading

$2.00 +0.01 (+0.50%)

As of 10/13/2026 07:30 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NNOX, INGN, STIM, and FOCL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NNOX, INGN, STIM, and FOCL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NNOX, INGN, STIM, and FOCL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NNOX, INGN, STIM, and FOCL Company Descriptions

FocalTherics NASDAQ:FOCL

Inogen NASDAQ:INGN

Nano-X Imaging NASDAQ:NNOX

Neuronetics NASDAQ:STIM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NNOX, INGN, STIM, and FOCL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NNOX, INGN, STIM, and FOCL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NNOX, INGN, STIM, and FOCL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NNOX, INGN, STIM, and FOCL Company Descriptions

FocalTherics NASDAQ:FOCL

Inogen NASDAQ:INGN

Nano-X Imaging NASDAQ:NNOX

Neuronetics NASDAQ:STIM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools